Form 8-K - Current report:
SEC Accession No. 0001641172-25-015124
Filing Date
2025-06-13
Accepted
2025-06-13 17:15:37
Documents
15
Period of Report
2025-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44964
2 EX-10.1 ex10-1.htm EX-10.1 1438
3 GRAPHIC ex10-1_001.jpg GRAPHIC 513506
4 GRAPHIC ex10-1_002.jpg GRAPHIC 439249
  Complete submission text file 0001641172-25-015124.txt   1526090

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE imnn-20250613.xsd EX-101.SCH 3008
6 XBRL LABEL FILE imnn-20250613_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE imnn-20250613_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 251047698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)